LIVTENCITY 200 mg film-coated tablets.
MARIVEB
Approved small_molecule active
Quick answer
LIVTENCITY 200 mg film-coated tablets. for Transplant patients with high recurrent Epstein-Barr infection is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Transplant patients with high recurrent Epstein-Barr infection
- Phase
- Approved
- Modality
- small_molecule
- Status
- active